BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act.
BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act. N&O FILE PHOTO N&O FILE PHOTO
BioMerieux, which employs 800 people in Durham, manufactures blood culture bottles and instruments and reagents for bacterial testing. It expects increased business from biomedical firms that develop new diagnostic tests in response to new standards established 21st Century Cures Act. N&O FILE PHOTO N&O FILE PHOTO

Triangle biotech businesses big winners under new medical research law

December 20, 2016 05:26 PM

UPDATED December 21, 2016 08:55 AM

More Videos

  • Duke engineers create artificial heart muscle for heart attack victims

    Biomedical engineers at Duke have created a fully functioning artificial human heart muscle large enough to patch over damage typically seen in patients who have suffered a heart attack. The advance takes a major step toward the end goal of repairing dead heart muscle in human patients.